Latest Breaking News On - ப்ரையாரிடீ விமர்சனம் வவுச்சர் - Page 7 : comparemela.com

Broad Efficacy and Improved Safety Profile of HyBryte™ Presented at Society for Investigative Dermatology Virtual Meeting News provided by Share this article Share this article PRINCETON, N.J., May 4, 2021 /PRNewswire/  Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Ellen Kim, MD, Medical Director, Dermatology Clinic, Perelman Center for Advanced Medicine, Professor of Dermatology at the Hospital of the University of Pennsylvania, and the Lead Principal Investigator for the Phase 3 FLASH ( Fluorescent Synthetic Hypericin) study, presented confirmatory data at the Society for Investigative Dermatology (SID) Virtual Meeting, held May 3-8, 2021.  The presentation was selected to be shown during a Concurrent Mini-Symposium for Patient-Targeted Research. The presented data demonstrated the abil

Hellen kimUs congressBiomedical advanced researchNational institute of allergySociety for investigative dermatology virtual meetingSociety for investigative dermatologyDevelopment authorityExchange commissionSoligenix incPerelman centerEuropean medicines agencyHospital of the university pennsylvaniaOur public health solutionsDefense threat reduction agencyMedical directorDermatology clinic